Price Alert

Salarius Pharmaceuticals ... (SLRX)

NASDAQ: SLRX · Real-Time Price · USD

5.95

0.19 (3.30%)

At close: Aug 27, 2025, 3:59 PM

5.60

-5.88%

After-hours: Aug 27, 2025, 06:07 PM EDT

Salarius Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	794.89K	1.8M	2.43M	3.28M	3.27M	4.37M	5.9M	7.58M	11.54M	9.27M	12.11M	16.82M	22.65M	24.19M	29.21M	31.9M	33.08M	36.61M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	33.2K	34.31K	35.41K	36.52K	39.93K	53.39K	66.85K	80.44K	99.05K	114.85K	130.5K	-7.11M	1.77M	1.78M	1.8M	201.39K	216.79K	232.03K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	130K	130K	1.61M	n/a	n/a	n/a	n/a	2.09M	4.79M	4.22M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-525.44K	-0.00	n/a	n/a	n/a	n/a	n/a	-117.31K	n/a
Other Current Assets	564.69K	347.87K	265.25K	n/a	n/a	178.07K	151.27K	n/a	284.81K	525.44K	0.00	0.00	215.64K	595.12K	172.99K	95.23K	258.86K	206.49K
Total Current Assets	1.36M	2.31M	2.99M	3.82M	3.51M	4.83M	6.52M	8.32M	11.96M	9.94M	14.52M	17.97M	23.02M	24.86M	30.16M	35.18M	38.31M	41.65M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.19K	7.88K	11.57K	15.26K	18.95K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	8.87M	8.87M	8.87M	8.87M	8.87M	8.87M	8.87M
Total Long-Term Assets	33.2K	34.31K	35.41K	36.52K	39.93K	53.39K	66.85K	80.44K	99.05K	114.85K	130.5K	1.76M	10.64M	10.65M	10.67M	9.08M	9.1M	9.12M
Total Assets	1.39M	2.34M	3.02M	3.86M	3.55M	4.88M	6.59M	8.4M	12.06M	10.06M	14.65M	19.72M	33.65M	35.51M	40.83M	44.26M	47.4M	50.77M
Account Payables	1.48M	1.47M	936.99K	165.8K	643.05K	713.96K	602.85K	1.09M	2.29M	3.51M	2.86M	1.72M	1.87M	1.69M	1.54M	1.23M	1.28M	1.57M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	112.23K	221.87K	328.85K	n/a	116.86K	289.64K	459.09K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	191.4K
Other Current Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	8.71K	n/a	54.01K	63.08K	105.27K
Total Current Liabilities	1.48M	2.28M	1.51M	934.58K	1.18M	1.23M	1.3M	2.32M	3.64M	4.5M	4.27M	3.11M	2.77M	2.09M	2.11M	1.61M	1.55M	1.99M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	740.55K	694.63K	352.42K	439.93K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	740.55K	694.63K	352.42K	439.93K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	398.94K	n/a	n/a	n/a	n/a
Total Liabilities	2.22M	2.28M	1.51M	934.58K	1.18M	1.23M	1.3M	2.32M	3.64M	4.5M	4.27M	3.11M	2.77M	2.09M	2.11M	1.61M	1.55M	1.99M
Total Debt	n/a	112.23K	221.87K	328.85K	n/a	116.86K	289.64K	459.09K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	191.4K
Common Stock	213.00	208.00	144.00	144.00	64.00	431.00	393.00	394.00	335.00	246.00	225.00	224.00	5.61K	4.67K	4.52K	4.52K	4.48K	4.47K
Retained Earnings	-84.59M	-83.63M	-81.92M	-80.46M	-79.49M	-78.06M	-76.35M	-75.47M	-73.02M	-69.15M	-63.81M	-57.43M	-43.02M	-38.31M	-32.2M	-28.09M	-24.36M	-21.28M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	0.00	n/a	-0.00	0.00	0.00
Shareholders Equity	-829.72K	61.87K	1.51M	2.92M	2.38M	3.65M	5.29M	6.08M	8.41M	5.56M	10.38M	16.61M	30.88M	33.42M	38.72M	42.65M	45.85M	48.78M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.61M	1.61M	n/a	1.61M	n/a	n/a	n/a